"10.1371_journal.pone.0056048","plos one","2013-02-14T00:00:00Z","Isabelle Jaussent; Jean-Philippe Empana; Marie-Laure Ancelin; Alain Besset; Catherine Helmer; Christophe Tzourio; Karen Ritchie; Jean Bouyer; Yves Dauvilliers","Inserm, U1061, Montpellier, France; Université Montpellier 1, Montpellier, France; Paris Cardiovascular Research Centre (PARCC), University Paris Descartes, Sorbonne Paris Cité, UMR-S970, Paris, France; Inserm, U897, Bordeaux, France; Université Victor Segalen Bordeaux 2, ISPED, Bordeaux, France; Faculty of Medicine, Imperial College, London, United Kingdom; Inserm, CESP Centre for research in Epidemiology and Population Health, U1018, Reproduction and Child Development, Villejuif, France; Univ Paris Sud, UMR-S1018, Villejuif, France; CHU Montpellier, Service de Neurologie, Unité des Troubles du Sommeil, Hôpital Gui-de-Chauliac, Montpellier, France","Revised the manuscript: CH CT KR. Conceived and designed the experiments: IJ JB YD. Performed the experiments: IJ MLA YD. Analyzed the data: IJ JPE MLA AB JB YD. Contributed reagents/materials/analysis tools: IJ JB MLA YD. Wrote the paper: IJ YD.","Isabelle Jaussent, Dr. Jean Bouyer, Dr. Marie-Laure Ancelin, Dr. Catherine Helmer and Dr. Alain Besset report no disclosures. Dr. Jean-Philippe Empana has received consultancy honoraria from Lundbeck and speaker honoraria from Pfizer. Dr. Karen Ritchie serves on scientific advisory boards for the Biomedical Research Centre, Kings College London, and MRC Strategic Steering Committee (Longitudinal Health and Aging Research Unit); and serves on the editorial advisory boards of the International Journal of Geriatric Psychiatry, Dementia, International Psychogeriatrics, Journal of Clinical and Experimental Gerontology, Psychogeriatrics, Neuronale, Neurologie-Psychiatrie-Gériatrie, and Gerontology. Dr. Christophe Tzourio has received fees from the Fondation Plan Alzheimer, the Fondation de Recherche sur lHypertension Artérielle, and the ABBOTT company for participating in scientific committees. He has also received investigator-initiated research funding from the French National Research Agency (ANR) and the Fondation Plan Alzheimer for the 3C study. He serves on the editorial advisory board of Neuroepidemiology, Journal of Hypertension, and Journal of Alzheimers disease. Pr. Yves Dauvilliers has received funds for speaking and board engagements with UCB pharma, Cephalon, Jazz, Novartis, and Bioprojet. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Isabelle Jaussent","IJ",9,TRUE,3,3,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
